MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...
The Hearty Soul on MSN3d
10+ Side Effects of The Controversial Medication, Gabapentin
Gabapentin is classed as an antiseizure medication used to treat several conditions. Typically, it is used for conditions ...
USA Today27d
What is gabapentin? Here's why it's so controversial.
When used as directed, gabapentin is known to have numerous uses and benefits. It has been FDA-approved to help control and treat seizures and to diminish a specific type of nerve pain called post ...
MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain
Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...
Knowridge12d
A new drug brings hope for chronic nerve pain relief
Researchers from Weill Cornell Medicine and the Burke Neurological Institute have developed a new drug that could make a big difference for people suffering from chronic nerve pain. This condition, ...
Sacramento Bee7d
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study
Expanding Ketamir-2's Potential Beyond Neuropathic Pain: MIRA is actively preparing to launch preclinical trials for post-traumatic stress disorder (PTSD), recognizing the urgent need for non ...
MIRA says Ketamir-2 outperforms FDA-approved neuropathic pain treatments
MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...